Abstract
AimThis study aims to assess the impact of continued ranibizumab treatment for neovascular age-related macular degeneration on patients from the MARINA and ANCHOR randomised clinical studies who lost ≥3 lines...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have